Guidance for industry, q & a
Subtitle: content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products
Contributors: Center for Biologics Evaluation and Research (U.S.)
Publisher: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research
Published: 2000
Place of publication: Rockville, MD
Language: eng
Format: [electronic resource] :
Subjects: Experimental Medicine; Biotechnology; Research
Other titles: Guidance for industry, questions and answers; Content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
Notes: "Pharmacology/toxicology."

"October 2000."